Customer Letters

Please note: The following Customer Letters, do not replace the version that you receive from your local Canadian Blood Services site.

* The contents of the customer letters available on this site are current as of their dates of publication. If required, contact your local Hospital Liaison Specialist to determine if the letter is still current.

Displaying 1 - 12 of 12

	Date Sort ascending
CL_2023-12.pdf	2023-05-16	ACTION REQUIRED National Deployment of Pathogen-Reduced Platelets: Fourth Update Customer Letter 2023-12 (PDF)
CL_2023-11.pdf	2023-04-27	INFORMATION ONLY FAQ for the Request for Proposals (RFP) for Immunoglobulins and other Plasma Protein and Related Products (PPRP) Customer Letter 2023-11 (PDF) \| 2023 IVIg Transition FAQ (PDF)
CL_2023-10.pdf	2023-04-14	ACTION REQUIRED Shelf Life Extension of Pooled Platelets Psoralen-Treated Components from 5 to 7 Days Customer Letter 2023-10 (PDF)
CL_2023-09.pdf	2023-04-03	ACTION REQUIRED National Deployment of Pathogen-Reduced Platelets: Third Update Customer Letter 2023-09 (PDF)
CL_2023-08.pdf	2023-03-24	INFORMATION ONLY Alprolix and Eloctate Packaging Changes Customer Letter 2023-08 (PDF) \| ALPROLIX Hemophilia B Enrolment Form (PDF) \| ELOCTATE Hemophilia A Enrolment Form (PDF) \| ALPROLIX - ELOCTATE Notification Letter (PDF)
CL_2023-07.pdf	2023-03-23	INFORMATION ONLY NAC Recommendations for the Use of Solvent-Detergent Plasma in Canada; Important Changes to Post Thaw Storage of Octaplasma Customer Letter 2023-07 (PDF) \| Octaplasma^®Advisory Letter (PDF)
CL_2023-06.pdf	2023-03-20	INFORMATION ONLY Vonvendi^® - Interim Plasma Protein and Related Products Review Decision Customer Letter 2023-06 (PDF)
CL_2023-05.pdf	2023-03-13	ACTION REQUIRED Information on Immunoglobulin Inventory Following Results of the Request for Proposals (RFP) for Plasma-Derived Plasma Protein and Related Products (PPRP) Customer Letter 2023-05 (PDF)
CL_2023-04.pdf	2023-02-07	INFORMATION ONLY Further Information on Expanded Use of Solvent Detergent Plasma: Education Materials and Ordering Information Customer Letter 2023-04 (PDF) \| Octaplasma^®Customer Letter (PDF) \| Octaplasma^® - Q&A for Transfusion Medicine Laboratory (PDF)
CL_2023-03.pdf	2023-02-06	ACTION REQUIRED National Deployment of Pathogen-Reduced Platelets: Second Update Customer Letter 2023-03 (PDF)
CL_2023-02.pdf	2023-01-27	INFORMATION ONLY Update to Label Changes for Rare International Red Blood Cells Customer Letter 2023-02 (PDF) \| Attachment 1 (PDF)
CL_2023-01.pdf	2023-01-10	INFORMATION ONLY Further Information on Expanded Use of Solvent Detergent Plasma: Updated Post Thaw Expiration, Sample Labels and Implementation Checklist Customer Letter 2023-01 (PDF) \| Recommended Solvent Detergent Plasma Hospital Implementation Checklist (PDF) \| Octaplasma: Blood Bank Communication (PDF) \| Octaplasma B Label Mockup (PDF) \| Octaplasma A Label Mockup (PDF) \| Octaplasma AB Label Mockup (PDF) \| Octaplasma O Label Mockup (PDF)